Preclinical Study of Immunological Isoxazole Derivatives as a Potential Support for Melanoma Chemotherapy

Preclinical Study of Immunological Isoxazole Derivatives as a Potential Support for Melanoma Chemotherapy

(1) Background: Melanoma is an aggressive neoplasm derived from melanocyte precursors with a high metastatic potential. Responses to chemotherapy and immunotherapy for melanoma remain weak, underlining the urgent need to develop new therapeutic strategies for the treatment of melanoma. (2) Methods:...

Full description

Bibliographic Details
Main Authors: Izabela Jęśkowiak, Benita Wiatrak, Adam Szeląg, Marcin Mączyński
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:International Journal of Molecular Sciences
Subjects:
skin cancer
skin diseases
isoxazole derivatives
melanoma
Online Access:https://www.mdpi.com/1422-0067/22/20/10920

Internet

https://www.mdpi.com/1422-0067/22/20/10920

Similar Items